Evidence map›Paper›PMID 42576999›Full record

ArticleIJID regions2026

Genomic characterization of carbapenem-resistant Gram-negative bacilli isolated from hospital wastewater in Niamey, Niger.

Oumou Hamidou, Abdourahamane Yacouba, Ounoussa Tapha, Issoufou Noma Massir, Ismael Illa Salifou, Aminata Mamane Daouda, Harouna Moussa, Souleymane Brah, Saidou Mamadou, Lamine Baba-Moussa

Abstract read
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oumou HamidouNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Abdourahamane YacoubaNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Ounoussa TaphaNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Issoufou Noma MassirNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Ismael Illa SalifouFaculty of Science and Technology, Abdou Moumouni University, Niamey, Niger.
Aminata Mamane DaoudaCentre de Recherche Médicale et Sanitaire, Niamey, Niger.
Harouna MoussaNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Souleymane BrahFaculty of Health Sciences, Abdou Moumouni University, Niamey, Niger.
Saidou MamadouNational Reference Laboratory for Antimicrobial Resistance, Amirou Boubacar Diallo National Hospital, Niamey, Niger.
Lamine Baba-MoussaDepartment of Biochemistry and Cell Biology, Faculty of Science and Technology, University of Abomey-Calavi, Cotonou, Benin.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aims to characterize the resistance gene profiles in cultured isolates and clonal diversity of bacterial isolates from wastewater collected at three major hospitals in Niamey. Methods: Samples of raw and treated wastewater were collected at the Niamey National Hospital, the Amirou Boubacar Diallo National Hospital, and the General Referral Hospital. An approach combining classical microbiology and whole-genome sequencing was used to identify bacterial species and characterize their carbapenem resistance mechanisms. Results: Analysis revealed a strong predominance of Conclusion: This preliminary study provides crucial baseline data on carbapenem resistance in hospital wastewater in Niamey. This study provides the first baseline genomic data on carbapenemases dynamics in hospital wastewater in Niamey. The persistence of international elite clones (ST11, ST773) and epidemic plasmids (IncFII, IncL, IncX3) throughout the treatment process underscores the ineffectiveness of current sanitation barriers. These findings necessitate the following actions: (i) the adoption of environmental genomic surveillance as an early warning system for emerging clinical clones, (ii) the revision of disinfection protocols to target the stability of mobile genetic elements, and (iii) the urgent integration of this approach into national action plans for combating antimicrobial resistance in Niger and West Africa to prevent irreversible environmental dissemination.

Indexed as

BacteriaCarbapenemasesGenesHospitalSequencingWastewater

Identifiers

PMID42576999
PMCPMC13453592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.